Publication | Closed Access
HIGHLY POTENT ADRENAL CORTICAL STEROIDS: STRUCTURE AND BIOLOGIC ACTIVITY
60
Citations
13
References
1955
Year
Clinical DisordersArticle1 November 1955HighlyAdrenal GlandHealth SciencesMedicinePhysiologyAdrenal HealthNovember 1955Reproductive EndocrinologyAdrenal DiseaseGlucocorticoidEndocrinologyPharmacologyEndocrine ResearchSteroid MetabolismAldosterone—a ReviewIntegrative Physiology
Article1 November 1955HIGHLY POTENT ADRENAL CORTICAL STEROIDS: STRUCTURE AND BIOLOGIC ACTIVITYGEORGE W. THORN, M.D., F.A.C.P., ALBERT E. RENOLD, M.D., WILLIAM I. MORSE, M.D., ALAN GOLDFIEN, M.D., WILLIAM J. REDDY, A.B.GEORGE W. THORN, M.D., F.A.C.P.Search for more papers by this author, ALBERT E. RENOLD, M.D.Search for more papers by this author, WILLIAM I. MORSE, M.D.Search for more papers by this author, ALAN GOLDFIEN, M.D.Search for more papers by this author, WILLIAM J. REDDY, A.B.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-43-5-979 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptSynthetic adrenal steroids possessing biologic activity greater than that of the naturally occurring secretory products of the adrenal cortex are of considerable theoretic importance and, in certain instances, may offer unusual opportunities for hormone therapy. Furthermore, it is of particular interest that the isolation and identification of a very active, naturally occurring sodium-retaining adrenal steroid (aldosterone) should have coincided with the synthesis of derivatives of hydrocortisone possessing physiologic activities manyfold greater than those of any previously known naturally occurring steroid. In 1954 Reichstein announced the identification and crystallization of "aldosterone," a naturally occurring adrenal steroid first described by Simpson and...Bibliography1. SimpsonTaitBush SAJFIE: Secretion of a salt-retaining hormone by the mammalian adrenal cortex, Lancet 2: 226, 1952. CrossrefMedlineGoogle Scholar2. SimpsonTaitWettsteinHehervon EuwSchindlerReichstein SAJFARJOT: Die Konstitution des Aldosterons. Über Bestandteiler der Nebennierenrinde und verwandte Stoffe, Helv. chem. acta 37: 1200, 1954. CrossrefGoogle Scholar3. MachFabreDuckertBorthDucommun RSJARP: Action clinique et metabolique de l'aldosterone (electrocortine), Schweiz. med. Wchnschr. 84: 407, 1954. MedlineGoogle Scholar4. GauntRenziChart RAAJJ: Aldosterone—a review, J. Clin. Endocrinol. and Metabolism 15: 621, 1955. CrossrefGoogle Scholar5. FriedSabo JEF: 9 Alpha-fluoro derivatives of cortisone and hydrocortisone, J. Am. Chem. Soc. 76: 1455, 1954. CrossrefGoogle Scholar6. BormanSingerNumerof AFMP: Growth-survival and sodium-retaining activity of 9 α-halo derivatives of hydrocortisone, Proc. Soc. Exper. Biol. and Med. 86: 570, 1954. CrossrefMedlineGoogle Scholar7. HerzogNobileTolksdorfCharneyHershbergPerlmanPechet HLASWEBPLMM: New antiarthritic steroids, Science 121: 176, 1955. CrossrefMedlineGoogle Scholar8. BunimPechetBollet JJMMAJ: Studies on metacortandralone and metacortandracin in rheumatoid arthritis, J. A. M. A. 157: 311, 1955. CrossrefMedlineGoogle Scholar9. ReddyJenkinsThorn WJDGW (a) : Estimation of 17-hydroxycorticoids in urine, Metabolism 1: 511, 1952. (b) Reddy, W. J.: Modification of the Reddy-Jenkins-Thorn method for the estimation of 17-hydroxycorticoids in urine, Metabolism 3: 489, 1954. MedlineGoogle Scholar10. DrekterHeislerScismSternPearsonMcGavack IJAGRSSTH: The determination of urinary steroids. I. The preparation of pigment-free extracts and a simplified procedure for the estimation of total 17-ketosteroids, J. Clin. Endocrinol. and Metabolism 12: 55, 1952. CrossrefGoogle Scholar11. HoltorffKoch AFFC: The colorimetric estimation of 17-ketosteroids and their application to urine extracts, J. Biol. Chem. 135: 377, 1940. CrossrefGoogle Scholar12. ForshamThornPruntyHills PHGWFTAG: Clinical studies with pituitary adrenocorticotropin, J. Clin. Endocrinol. 8: 15, 1948. CrossrefMedlineGoogle Scholar13. RenoldFroesch AEER: In preparation. Google Scholar14. GoldfienLaidlawAbu HaydarRenoldThorn AJCNAEGW: Fluorohydrocortisone and chlorohydrocortisone, highly potent derivatives of Compound F, New England J. Med. 252: 415, 1955. CrossrefMedlineGoogle Scholar15. RenoldAbu HaydarReddyGoldfienSt. MarcLaidlaw AENWJAJRJC: Biological effects of fluorinated derivatives of hydrocortisone and progesterone in man, Ann. New York Acad. Sc., in press. Google Scholar16. ThornLaidlawGoldfien GWJCA: Studies on the sodium-retaining effect of adrenocortical steroids, Ciba's Colloquia on Endocrinology, Vol. 8, 1955, The Blakiston Company, Philadelphia, p. 343. Google Scholar17. ThornSheppardMorseReddyBeigelmanRenold GWRHWIWJPMAE: Comparative action of aldosterone and 9α-fluorohydrocortisone, Ann. New York Acad. Sc., in press. Google Scholar18. HallMcCrackenThorn TCBHGW: Skin pigmentation in relation to adrenal cortical function, J. Clin. Endocrinol. and Metabolism 13: 243, 1953. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Boston, Massachusetts*Presented as the John Phillips Memorial Lecture at the Thirty-sixth Annual Session of The American College of Physicians, Philadelphia, Pennsylvania, April 27, 1955.From the Departments of Medicine, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts.These studies were supported by funds from the National Institutes of Health of the United States Public Health Service; the John A. Hartford Foundation, Incorporated, New York; and the Eugene Higgins Trust of the Harvard Medical School.†Also designated as prednisolone (Δ1-hydrocortisone) and prednisone (Δ1-cortisone). PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byNeuronal and hormonal perturbations in postural tachycardia syndromeSteroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapyLife-Threatening Hypokalemia in an Asthmatic Patient Treated with High-Dose HydrocortisoneDrug Information RoundsThe effect of fludrocortisone acetate on plasma volume and natriuresis in patients with aneurysmal subarachnoid hemorrhage4 Exogenous mineralocorticoid-like disordersMineralocorticoid hypertension due to a nasal spray containing 9α-fluoroprednisoloneEffect of mineralocorticoid replacement therapy on renal acid-base homeostasis in adrenalectomized patientsMetabolic Effects of Cloprednol-A New Systemic CorticosteroidPotassium supplements in patients treated with corticosteroidsThe transplacental passage of prednisone and prednisolone in pregnancy near termThe metabolism of hypertensionRapid estimation of 1-dehydro-17-α-methyltestosterone produced by microbiological oxidation of 17-α-methyltestosteroneActivities of Adrenocorticosteroids in Experimental Animals and ManStudies on an Intermittent Corticosteroid Dosage RegimenThe effect of aldosterone on electrolytes and on digital vascular reactivity to I-norepinephrine in normotensive, hypertensive, and hypotensive subjectsVergleichende Untersuchungen über die Wirkung der Cortisone auf den KohlenhydratstoffwechselDie Therapie mit Glucocorticoiden (Substitution, Hemmwirkung, Therapie mit pharmakologischen Dosen)Eiwei�- und Elektrolytver�nderungen im Blut und Urin w�hrend des akuten Stadiums nach Sch�del-Hirnverletzungen und nach HirnoperationenPathophysiologie der HerzinsuffizienzSuccessful Treatment of Orthostatic Hypotension with 9-Alpha-FluorohydrocortisoneEFFECTS OF ANTI-INFLAMMATORY STEROIDS ON ELECTROLYTE METABOLISM*EFFECTS OF ANTI-INFLAMMATORY STEROIDS ON CARBOHYDRATE METABOLISM, WITH EMPHASIS ON HYPO-GLYCEMIC AND DIABETIC STATES*THE DIAGNOSIS AND TREATMENT OF ADDISON'S DISEASESpectrophotometric Determination of Residual Δ 4 -3-Ketosteroids in Bulk Δ 1,4 -3-Ketosteroids. Differential Rates of Thiosemicarbazone FormationDetermination of Bound Styrene in Raw and Cured Polymers by NitrationRHEUMATISM AND ARTHRITIS: REVIEW OF AMERICAN AND ENGLISH LITERATURE OF RECENT YEARS (TWELFTH RHEUMATISM REVIEW)* Part IICHARLEY J. SMYTH, M.D., F.A.C.P., JOSEPH J. BUNIM, M.D., F.A.C.P., WILLIAM S. CLARK, M.D., F.A.C.P., DARRELL C. CRAIN, M.D., F.A.C.P., FELIX E. DEMARTINI, M.D., IVAN F. DUFF, M.D., F.A.C.P., EPHRAIM P. ENGLEMAN, M.D., F.A.C.P., DONALD C. GRAHAM, M.D., F.R.C.P. (C), MAX M. MONTGOMERY, M.D., F.A.C.P., BERNARD M. NORCROSS, M.D., F.A.C.P., HOWARD F. POLLEY, MARIAN W. ROPES, M.D., F.A.C.P., EDWARD F. ROSENBERG, M.D., F.A.C.P.Triamcinolone in the treatment of allergic conditionsAddison's disease in childrenSynthetic Derivatives of Cortical HormonesObservations on new synthetic antirheumatic steroids and critical evaluation of prednisone therapy in rheumatoid arthritisDie NebennierenrindeThe Treatment of Adrenal DysfunctionClinical and Metabolic Effects of 1-Dehydro-9-Alpha-Fluoro Hydrocortisone AcetateChemie und Biologie neuer CorticoideChemie und Biologie neuer Corticoide 1 November 1955Volume 43, Issue 5Page: 979-1000KeywordsAldosteroneBiologicsExcretionHormonal therapyHormonesHospital medicineMedical servicesOral administrationSteroidsUric acid ePublished: 1 December 2008 Issue Published: 1 November 1955 PDF downloadLoading ...
| Year | Citations | |
|---|---|---|
Page 1
Page 1